Ratio of mBDNF to proBDNF for Differential Diagnosis of Major Depressive Disorder and Bipolar Depression - PubMed

Affiliations

• PMID: 27613282
• DOI: 10.1007/s12035-016-0098-6

Ratio of mBDNF to proBDNF for Differential Diagnosis of Major Depressive Disorder and Bipolar Depression

Guoqing Zhao et al. Mol Neurobiol. 2017 Sep.

Abstract

There is a high rate of misdiagnosis between major depressive disorder (MDD) and bipolar disorder (BD) in clinical practice. Our previous work provided suggestive evidence for brain-derived neurotrophic factor (BDNF) in differentiating BD from MDD. In this study, we aimed to investigate the role of mature BDNF (mBDNF) and its precursor (proBDNF) in distinguishing bipolar depression (BP) from MDD during acute depressive episode. A total of 105 participants, including 44 healthy controls, 37 MDD patients and 24 BP patients, were recruited. Enzyme-linked immunosorbent assay kits were applied to measure plasma mBDNF levels and proBDNF levels of all participants. Plasma mBDNF levels were significantly decreased in BP group than those in MDD group (P = 0.001) and healthy controls (P = 0.002). Significantly higher ratio of mBDNF to proBDNF (M/P) at baseline was showed in MDD group than those in BP group as well as in healthy controls (P = 0.000 and P = 0.000, respectively). The optimal model for discriminating BP was the M/P ratio (area under the ROC curve = 0.858, 95 % CI 0.753-0.963). Furthermore, the M/P ratio was restored to normal levels after antidepressants treatment in MDD group. In summary, our data demonstrated that both plasma mBDNF levels and M/P ratio were lower in BP compared with MDD. These findings further support M/P ratio as a potential differential diagnostic biomarker for BP among patients in depressive episodes.

Keywords: Bipolar disorder; Brain-derived neurotrophic factor; Major depressive disorder; Precursor.

Similar articles

• Analysis of blood mature BDNF and proBDNF in mood disorders with specific ELISA assays.

  Lin L, Fu XY, Zhou XF, Liu D, Bobrovskaya L, Zhou L. Lin L, et al. J Psychiatr Res. 2021 Jan;133:166-173. doi: 10.1016/j.jpsychires.2020.12.021. Epub 2020 Dec 13. J Psychiatr Res. 2021. PMID: 33341455

• Brain-derived neurotrophic factor levels and bipolar disorder in patients in their first depressive episode: 3-year prospective longitudinal study.

  Li Z, Zhang C, Fan J, Yuan C, Huang J, Chen J, Yi Z, Wang Z, Hong W, Wang Y, Lu W, Guan Y, Wu Z, Su Y, Cao L, Hu Y, Hao Y, Liu M, Yu S, Cui D, Xu L, Song Y, Fang Y. Li Z, et al. Br J Psychiatry. 2014 Jul;205(1):29-35. doi: 10.1192/bjp.bp.113.134064. Epub 2014 Apr 24. Br J Psychiatry. 2014. PMID: 24764546

• The serum protein levels of the tPA-BDNF pathway are implicated in depression and antidepressant treatment.

  Jiang H, Chen S, Li C, Lu N, Yue Y, Yin Y, Zhang Y, Zhi X, Zhang D, Yuan Y. Jiang H, et al. Transl Psychiatry. 2017 Apr 4;7(4):e1079. doi: 10.1038/tp.2017.43. Transl Psychiatry. 2017. PMID: 28375203 Free PMC article.

• BDNF as a biomarker for successful treatment of mood disorders: a systematic & quantitative meta-analysis.

  Polyakova M, Stuke K, Schuemberg K, Mueller K, Schoenknecht P, Schroeter ML. Polyakova M, et al. J Affect Disord. 2015 Mar 15;174:432-40. doi: 10.1016/j.jad.2014.11.044. Epub 2014 Nov 29. J Affect Disord. 2015. PMID: 25553404 Review.

• Brain-derived neurotrophic factor as a biomarker for mood disorders: an historical overview and future directions.

  Hashimoto K. Hashimoto K. Psychiatry Clin Neurosci. 2010 Aug;64(4):341-57. doi: 10.1111/j.1440-1819.2010.02113.x. Psychiatry Clin Neurosci. 2010. PMID: 20653908 Review.

Cited by

• Corticosterone Induced the Increase of proBDNF in Primary Hippocampal Neurons Via Endoplasmic Reticulum Stress.

  Liu Y, Zou GJ, Tu BX, Hu ZL, Luo C, Cui YH, Xu Y, Li F, Dai RP, Bi FF, Li CQ. Liu Y, et al. Neurotox Res. 2020 Aug;38(2):370-384. doi: 10.1007/s12640-020-00201-4. Epub 2020 May 6. Neurotox Res. 2020. PMID: 32378057

• Increased Serum Levels of Brain-Derived Neurotrophic Factor Contribute to Inflammatory Responses in Patients with Rheumatoid Arthritis.

  Lai NS, Yu HC, Huang Tseng HY, Hsu CW, Huang HB, Lu MC. Lai NS, et al. Int J Mol Sci. 2021 Feb 12;22(4):1841. doi: 10.3390/ijms22041841. Int J Mol Sci. 2021. PMID: 33673283 Free PMC article. Clinical Trial.

• Can Brain-Derived Neurotrophic Factor Be Considered a Biomarker for Bipolar Disorder? An Analysis of the Current Evidence.

  De Felice G, Luciano M, Boiano A, Colangelo G, Catapano P, Della Rocca B, Lapadula MV, Piegari E, Toni C, Fiorillo A. De Felice G, et al. Brain Sci. 2023 Aug 20;13(8):1221. doi: 10.3390/brainsci13081221. Brain Sci. 2023. PMID: 37626577 Free PMC article. Review.

• Clinical Improvement in Depression and Cognitive Deficit Following Electroconvulsive Therapy.

  Ahmad Hariza AM, Mohd Yunus MH, Murthy JK, Wahab S. Ahmad Hariza AM, et al. Diagnostics (Basel). 2023 Apr 28;13(9):1585. doi: 10.3390/diagnostics13091585. Diagnostics (Basel). 2023. PMID: 37174977 Free PMC article. Review.

• Associations of BDNF/BDNF-AS SNPs with Depression, Schizophrenia, and Bipolar Disorder.

  Shkundin A, Halaris A. Shkundin A, et al. J Pers Med. 2023 Sep 18;13(9):1395. doi: 10.3390/jpm13091395. J Pers Med. 2023. PMID: 37763162 Free PMC article. Review.

References

Publication types

MeSH terms

Substances

LinkOut - more resources

• Full Text Sources

  • Springer

• Other Literature Sources

  • scite Smart Citations

• Medical

  • MedlinePlus Consumer Health Information
  • MedlinePlus Health Information